Trials / Conditions / Stage IV Oropharyngeal Squamous Cell Carcinoma

Stage IV Oropharyngeal Squamous Cell Carcinoma

4 registered clinical trials studyying Stage IV Oropharyngeal Squamous Cell Carcinoma.

Status	Trial	Sponsor	Phase
Completed	Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell NCT03422536	University of Arizona	Phase 2
Completed	Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carc NCT03342911	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 2
Completed	Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Can NCT03032250	Wake Forest University Health Sciences	N/A
Completed	Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer NCT00458978	National Cancer Institute (NCI)	Phase 2